A drug commonly taken to prevent seizures in epilepsy may surprisingly protect the eyesight of people with multiple sclerosis (MS), according to a study released April 16, 2015 that will be…
Category: News
Clarity Medical’s RetCam Will Be Used in a Worldwide Clinical Study for the Treatment of Premature Infant Ocular Disease
PLEASANTON, Calif.–(BUSINESS WIRE)–Clarity Medical Systems, Inc., a developer and marketer of ophthalmic diagnostic imaging technologies, is pleased to announce that their product, RetCam, will be utilized to image premature infant eyes in a study to evaluate a potential new method for treating Retinopathy of Prematurity (ROP) using Lucentis™ (ranibizumab). “The use of RetCam in a study of this medical significance demonstrates the growing worldwide acceptance of RetCam for pediatric retinal
Researchers use virtual reality to develop new method for measuring balance control in glaucoma patients
Falls are the leading cause of injury-related death and morbidity in older adults, especially those with a chronic eye disease such as glaucoma. To investigate this problem, a multidisciplinary group of researchers has become the first to use virtual r…
Treatment that slows AMD vision loss with one stem cell injection shows promise
Researchers are optimistic that a stem cell treatment they successfully tested in rats will slow or reverse the effects of early-stage age-related macular degeneration in humans.
Study challenges view that sight-based brain sensory network organization is impaired with blindness
Is visual input essential to how the topographical map of the visual cortex develops in the human brain?
Stem cell injection may soon reverse vision loss due to age-related macular degeneration
An injection of stem cells into the eye may soon slow or reverse the effects of early-stage age-related macular degeneration, according to new research from scientists at Cedars-Sinai.
Preoperative Tests Still Too Frequent for Cataract Surgery
Preoperative medical tests are still being ordered too frequently for Medicare patients undergoing cataract surgery, despite evidence that such tests have no effect on surgical outcomes. Medscape Medical News
Clinical research study demonstrates EyePromise EZ Tears relieves dry eye symptoms and discomfort fast
People suffering with burning, red, irritated, or watering eyes now have a proven oral nutritional supplement available to them that starts relieving these symptoms within a week.
BioLight Life Sciences announces first IOPtiMateâ„¢ system sale in Hungary
BioLight Life Sciences Investments Ltd., a firm that invests in, manages and commercializes biomedical innovations in ophthalmology and cancer diagnostics, today announced the first sale of the IOPtiMate™ system to a medical center located in Hungary.
IRIS Fundus Camera Automatically Spots Eye Conditions (VIDEO)
Intelligent Retinal Imaging Systems, a company out of Pensacola, Florida, received FDA clearance for its IRIS automated fundus camera for screening patients for diabetic retinopathy, macular edema, glaucoma, and other eye related conditions. The device, the first of its kind, doesn’t require professional ophthalmolog (Read more...)
Bringing Eye Care to the Community
A collaboration between Wills Eye Hospital and the Centers for Disease Control and Prevention helps underserved, high-risk patients to be treated for glaucoma through a community outreach program. Wills Eye Hospital
Calcium Supplementation Associated With Macular Degeneration
A study has shown a potential link between calcium supplementation and macular degeneration, particularly in those older than 68 years. Medscape Medical News
New potential treatment for age-related macular degeneration offers hope to patients as phase III trials begin in Bristol, UK
Patients in Bristol suffering from geographic atrophy can now enroll in the phase III clinical program for lampalizumab, a drug being investigated for this form of age-related macular degeneration…
Open-angle glaucoma: Poor data for the fixed combination tafluprost/timolol
Information on important outcomes is lacking, no advantages shown for side effectsThe fixed combination of the drugs tafluprost and timolol (trade name: Taptiqom) has been approved in Germany…
Novel therapeutic procedure helps stroke patient recover three-dimensional vision
Impaired vision is one of the most common consequences of a stroke. In rare cases, patients may even lose their ability to perceive depth.
Study Identifies Medium Drusen That May Signal Worsening AMD
Finding medium drusen plus retinal pigment abnormalities appears to signal a greater likelihood of progression to late-stage AMD. Medscape Medical News
Bad News: Medical Misinformation and the Ethics of TV Docs
Henry Black and George Lundberg on combating the misinformation in consumer medical news, the ethics of the physician as entertainer, and other ills that plague medical reporting. Medscape Cardiology
Sen. Rand Paul, MD, Announces Presidential Run
The ophthalmologist-turned-politician said he and his supporters “have come to take our country back” from special interests and a “Washington machine that gobbles up our liberties.”
Medscape Medical News
Just How Common Is Hydroxychloroquine Retinopathy?
Addressing an ongoing debate, a new study seeks clarity about the prevalence of this treatment-induced condition, as well as its leading risk factors. Medscape Optometry
Morning Break: Dr. Paul Declares; Go Ask Alice; Hamburg’s New Job
(MedPage Today) — Health news and commentary from around the Web, gathered by the MedPage Today staff.